Eli Lilly and Company (SWX:LLY)
Switzerland · Delayed Price · Currency is CHF 795.00
+15.00 (1.92%)
At close: Jan 30, 2026
Eli Lilly and Company Market Cap
Eli Lilly and Company has a market cap or net worth of 715.96 billion as of January 30, 2026. Its market cap has increased by 16.75% in one year.
Market Cap
715.96B
Enterprise Value
740.94B
Revenue
47.38B
Ranking
n/a
PE Ratio
48.77
Stock Price
795.00
Market Cap Chart
Since July 9, 1970, Eli Lilly and Company's market cap has increased from 3.09B to 715.96B, an increase of 23,065.46%. That is a compound annual growth rate of 10.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 703.95B | -7.74% |
| Dec 31, 2025 | 763.01B | 21.13% |
| Dec 31, 2024 | 629.92B | 42.70% |
| Dec 29, 2023 | 441.43B | 37.33% |
| Dec 30, 2022 | 321.43B | 40.80% |
| Dec 31, 2021 | 228.28B | 68.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 299.12B |
| Novartis AG | 223.58B |
| Lonza Group AG | 39.22B |
| Galderma Group AG | 35.14B |
| Alcon | 30.44B |
| Sandoz Group AG | 27.57B |
| Straumann Holding AG | 15.41B |
| Sonova Holding AG | 12.71B |